|For Apheresis Professionals|
Journal of Clinical Apheresis - Special Issue (Volume 25, 2010)The highlight of the Fifth Special Issue
is the redefinition of the Indication Categories and the adaption of the GRADE
system for classifying the strength of the clinical recommendations based on
the quality of the available published evidence.
Clinical Applications of Therapeutic Apheresis: An Evidence Based Approach. 5th Edition
The decoupling of
the Indication Categories from both the type and quality of evidence and from
the strength of recommendations renders them of more practical value.Categories I and II now signify first-line or
second-line therapy respectively, and nothing more. Category IV still signifies
“not recommended” and, for the first time, the strength of that
(non)recommendation and the quality of evidence that undergirds it are separately
provided using GRADE system.
The most noteworthy is the redefinition of Category III to signify not whether the evidence is conclusive or inconclusive, but rather to signify when the specific role of apheresis in a give clinical indication has not been definititively determined.$75 (Members in North America) $85 (Members outside of North America) $100 (Non-members) Order Now
Take advantage of these discounted rates:
$70/copy when you purchase 10-20 copies
$65/copy when you purchase 21-50 copies
$60/copy when you purchase over 50 copies
Click here for the Bulk Order Form
A working group of the Apheresis Applications Committee developed the Fourth Special Issue, building upon the previously published Special Issues of 1986, 1993, and 2000. The key change in the 2007 edition from previous Special Issues is the introduction of the comprehensive Fact Sheet format designed to summarize and condense the available medical literature pertaining to the treatment of a disease by apheresis into a succinct review focusing on practical issues for the apheresis practitioner. Each fact sheet serves as a quick reference and includes such information as assigned ASFA category, disease incidence, number of patients reported to have been treated, types of reports appearing in the medical literature, level of evidence for therapeutic apheresis use, general disease description and treatment, rationale for apheresis, recommended apheresis regimen, and parameters for discontinuation.
“This is the first time that each disease is presented as a Fact Sheet which summarizes the evidence for the use of therapeutic apheresis”, said Committee Chair, Zbigniew M. Szczepiorkowski, MD, PhD, FCAP, adding, “We have attempted to incorporate evidence based medicine into the well defined and widely accepted ASFA Categories.”
"ASFA wishes to thank Gambro BCT for their unrestricted support of this publication," said Beth H. Shaz, Co-chair of the Committee. "With the use of the ASFA website and the Journal of Clinical Apheresis, our goal is to continually update and add new fact sheets. Through the Apheresis Application Committee our goal is to publish the next Special Issue in 2010. We plan to invite other medical professional societies that utilize therapeutic apheresis to work with ASFA on the next issue."
Price: $37.5 (Members in North America) $42.5 (Members outside of North America) $50 (Non-members) Order Now
"Can we perform apheresis for this disease?" If you have ever been in this situation, this publication is a must have! Written by the ASFA Clinical Application Committee, and edited by Bruce C. McLeod, MD (Medical Director, Blood Center, Rush Medical Center, Chicago, IL) this Special Review Issue is packed with important information from experts in the field of therapeutic apheresis . It is an indespensible reference source for hematologists, pathologists neurologists, nephrologists , rheumatologists, general internists, family practitioners and all other professionals who care for patients treated by apheresis. This Special Review Issue covers therapeutic apheresis and is organized by categories of disease:
- Autoimmune and rheumatic diseases
- Hematological and oncological diseases
- Renal and metabolic diseases
- Neurological disorders
- Therapeutic pediatric apheresis
$35 (within North America) $45 (outside North America) Order Now
- Apheresis Instrumentation by Dobri Kiprov, MD
- Clinical Applications - Donor by Sheryl Kempin, RN, BSHA
- Clinical Applications - Therapeutic by Vladimir Vidanovic, MD
- Pediatric Considerations by Christine Fernandez-Roig, RN, MSN
- Regulatory Considerations in the Donor Room by Wanda Koetz, RN, HP(ASCP)
- Regulatory Considerations Therapeutic by Jennifer Anderson RN, HP(ASCP) and Debbie Ferrell,RN, MSN, HP(ASCP)
- Donor and Patient Care - by Regina Rohe, RN, HP(ASCP)
- Access Issues - by Salil Joshi, MD
The session materials, including presentation slides and handouts are available for purchase here.
$75 (ASFA Members) $100 (Non-Members) Order Now
This invaluable textbook, published by ASFA, provides a basic overview of the theory and applications of apheresis and can serve as a basis for developing training programs for those new to the field of apheresis. Topics covered include:
- Basic Science
- Apheresis Instrumentation
- Clinical Application
- Donor Apheresis
- Apheresis Program Management Essentials
- Therapeutic Apheresis Essentials
- Regulatory Issues and Quality Activities
- Apheresis Math and Useful Physical Constants
This concise handbook, designed to fit conveniently in your lab coat pocket, is published jointly by ASFA and AABB.
- Introduction to Therapeutic Apheresis: Principles, Physiology and Patient Management
- Therapeutic Plasma Exchange
- Red Cell Exchange
- Pediatric Therapeutic Apheresis
- Selective Depletion
$40 (ASFA Members) $60 (Non-Members) Order from AABB
To receive the ASFA member discount, please call AABB directly at 301.215.6499.